首页> 外文期刊>Hematological oncology >High density of CD68+/CD163+tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma

【24h】

High density of CD68+/CD163+tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma

机译：诊断为高密度CD68 + / CD163 +肿瘤相关巨噬细胞（M2-TAM）与不良预后因素以及弥漫性大B细胞淋巴瘤患者不良临床预后密切相关

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hematological oncology》 |2015年第2期|共3页
作者
Marchesi Francesco; Cirillo Mariangela; Bianchi Antonella; Gately Michela; Olimpieri Odoardo M.; Cerchiara Elisabetta; Renzi Daniela; Micera Alessandra; Balzamino Bjorn O.; Bonini Stefano; Muda Andrea Onetti; Avvisati Giuseppe;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. High density of CD68+/CD163+tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma [J] . Marchesi Francesco, Cirillo Mariangela, Bianchi Antonella, Hematological oncology . 2015,第2期

机译：诊断为高密度CD68 + / CD163 +肿瘤相关巨噬细胞（M2-TAM）与不良预后因素以及弥漫性大B细胞淋巴瘤患者不良临床预后密切相关
2. Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis. [J] . Hasselblom S, Hansson U, Sigurdardottir M, Pathology International . 2008,第8期

机译：CD68 +肿瘤相关巨噬细胞在弥漫性大B细胞淋巴瘤患者中的表达及其与预后的关系。
3. High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma [J] . Qi-chun Cai, Hong Liao, Su-xia Lin, Medical Oncology . 2012,第4期

机译：弥漫性大B细胞淋巴瘤患者肿瘤浸润巨噬细胞高表达与预后不良相关
4. Clinical significance and expression of microRNA-21 in diffuse large B-cell lymphoma cell lines and serum of patients [C] . CHEN Wei-qun, LU Honf-da, KONG De-yong, 2011 Asia-Pacific Conference of tumor biology and medicine . 2011

机译：患者弥漫性大B细胞淋巴瘤细胞株和血清中microRNA-21的表达及临床意义
5. Clinical outcomes and cost-effectiveness of white blood cell growth factors in elderly patients with non -Hodgkin's lymphoma: Findings from a large population-based cohort. [D] . Gruschkus, Stephen K. 2009

机译：非霍奇金淋巴瘤的老年患者的白细胞生长因子的临床结果和成本效益：基于大量人群的研究结果。
6. MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index [O] . Hanne Due, Rasmus Froberg Brøndum, Ken H. Young, 2020

机译：与R-CHOP单一药物成分相关的MicroRNAs可识别结局较差的弥漫性大B细胞淋巴瘤患者并为国际预后指标增加预后价值
7. MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system [O] . Sehui Kim, Soo Jeong Nam, Dohee Kwon, 2016

机译：MYC和BCL2过表达与纪念斯隆-凯特琳癌症中心的较高预后模型和中枢神经系统原发性弥漫性大B细胞淋巴瘤的临床预后不良相关

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号